Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice

Diabetes

Volumn 64, Issue 4, 2015, Pages 1120-1130

  Morinaga, Hidetaka ^a   Mayoral, Rafael ^a,b   Heinrichsdorff, Jan ^a   Osborn, Olivia ^a   Franck, Niclas ^a   Hah, Nasun ^c   Walenta, Evelyn ^a   Bandyopadhyay, Gautam ^a   Pessentheiner, Ariane R ^a,d   Chi, Tyler J ^a   Chung, Heekyung ^a   Bogner Strauss, Juliane G ^d   Evans, Ronald M ^c,e   Olefsky, Jerrold M ^a   Oh, Da Young ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; FLUORESCENT DYE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; CCR2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL HOMING; CELL LABELING; CELL SIZE; CELL SUBPOPULATION; DISEASE SEVERITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INNATE IMMUNITY; KUPFFER CELL; LEAN BODY WEIGHT; LIPID DIET; LIVER CELL; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECRUITED HEPATIC MACROPHAGE; RNA SEQUENCE; ADVERSE EFFECTS; ANIMAL; FATTY LIVER; GLUCONEOGENESIS; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DIET, HIGH-FAT; FATTY LIVER; GLUCONEOGENESIS; INTERLEUKIN-6; KUPFFER CELLS; LIVER; MACROPHAGES; MALE; MICE; MICE, OBESE; OBESITY; RECEPTORS, CCR2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962026512     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1238     Document Type: Article

References (59)

1. Olefsky JM, Courtney CH. Type 2 diabetes mellitus: Etiology, pathogenesis, and natural history. In Endocrinology. 5th ed. DeGroot LJ, Jameson JL, Eds. Philadelphia, W.B. Saunders and Company, 2005, p. 1093-1117
2. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012;15: 635-645
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444: 860-867
4. Curat CA, Wegner V, Sengenès C, et al. Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006;49: 744-747
5. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25: 4-7
6. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796-1808
7. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830
8. Gribble FM. Metabolism: A higher power for insulin. Nature 2005;434: 965-966
9. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 1992;90: 1323-1327
10. Olefsky JM, Garvey WT, Henry RR, Brillon D, Matthaei S, Freidenberg GR. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 1988;85: 86-105
11. Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014;510: 84-91
12. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116: 1793-1801
13. Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005;11: 183-190
14. Huang W, Metlakunta A, Dedousis N, et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010;59: 347-357
15. Jia L, Vianna CR, Fukuda M, et al. Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance. Nat Commun 2014;5: 3878
16. Obstfeld AE, Sugaru E, Thearle M, et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesityinduced hepatic steatosis. Diabetes 2010;59: 916-925
17. Oh DY, Morinaga H, Talukdar S, Bae EJ, Olefsky JM. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012;61: 346-354
18. Sheth K, Bankey P. The liver as an immune organ. Curr Opin Crit Care 2001;7: 99-104
19. Papackova Z, Palenickova E, Dankova H, et al. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: The evidence for the involvement of alternatively activated macrophages. Nutr Metab (Lond) 2012;9: 22
20. Wisse E. Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope. J Ultrastruct Res 1974;46: 499-520
21. Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007;117: 185-194
22. Nnalue NA, Shnyra A, Hultenby K, Lindberg AA. Salmonella choleraesuis and Salmonella typhimurium associated with liver cells after intravenous inoculation of rats are localized mainly in Kupffer cells and multiply intracellularly. Infect Immun 1992;60: 2758-2768
23. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142: 687-698
24. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9: 357-359
25. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010;11: R106
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate -A practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995;57: 289-300
27. Storey JD. A direct approach to false discovery rates. J Roy Stat Soc B 2002;64: 479-498
28. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102: 15545-15550
29. Klein I, Cornejo JC, Polakos NK, et al. Kupffer cell heterogeneity: Functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007;110: 4077-4085
30. Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 2011;54: 2185-2197
31. Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 2012;302: G1310-G1321
32. Deng ZB, Liu Y, Liu C, et al. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009;50: 1412-1420
33. Movita D, Kreefft K, Biesta P, et al. Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages. J Leukoc Biol 2012;92: 723-733
34. Lloyd CM, Phillips AR, Cooper GJ, Dunbar PR. Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. J Immunol Methods 2008;334: 70-81
35. Kamimoto M, Rung-Ruangkijkrai T, Iwanaga T. Uptake ability of hepatic sinusoidal endothelial cells and enhancement by lipopolysaccharide. Biomed Res 2005;26: 99-107
36. Ogawara K, Yoshida M, Higaki K, et al. Hepatic uptake of polystyrene microspheres in rats: Effect of particle size on intrahepatic distribution. J Control Release 1999;59: 15-22
37. Rung-ruangkijkrai T, Fujikura D, Kitamura H, Saito M, Iwanaga T. The expression of src-suppressed C kinase substrate (SSeCKS) and uptake of exogenous particles in endothelial and reticular cells. Arch Histol Cytol 2004;67: 135-147
38. DeLeve LD. Vascular liver disease and the liver sinusoidal endothelial cell. In Vascular Liver Disease: Mechanisms and Management. DeLeve LD, Garcia-Tsao G, Eds. Berlin, Germany, Springer Science+Business Media, 2011, p. 25-40
39. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-1231
40. Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123: 1705-1725
41. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122: 1649-1657
42. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50: 1844-1850
43. Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology 2014;147: 577, e1
44. Meli R, Mattace Raso G, Calignano A. Role of innate immune response in non-alcoholic Fatty liver disease: Metabolic complications and therapeutic tools. Front Immunol 2014;5: 177
45. Bikman BT, Summers SA. Ceramides as modulators of cellular and wholebody metabolism. J Clin Invest 2011;121: 4222-4230
46. Dressler KA, Mathias S, Kolesnick RN. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 1992;255: 1715-1718
47. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95: 2409-2415
48. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993;259: 87-91
49. Wiegmann K, Schütze S, Machleidt T, Witte D, Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994;78: 1005-1015
50. Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta 2009;1792: 1062-1072
51. Stienstra R, Saudale F, Duval C, et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferatoractivated receptor alpha activity. Hepatology 2010;51: 511-522
52. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009;27: 147-163
53. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005;33: 52-62
54. Diesselhoff-den Dulk MM, Crofton RW, van Furth R. Origin and kinetics of Kupffer cells during an acute inflammatory response. Immunology 1979;37: 7-14
55. van Furth R. Monocyte origin of Kupffer cells. Blood Cells 1980;6: 87-92
56. Parwaresch MR, Wacker HH. Origin and kinetics of resident tissue macrophages. Parabiosis studies with radiolabelled leucocytes. Cell Tissue Kinet 1984;17: 25-39
57. Yamamoto T, Naito M, Moriyama H, et al. Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. Am J Pathol 1996;149: 1271-1286
58. Ginhoux F, Jung S. Monocytes and macrophages: Developmental pathways and tissue homeostasis. Nat Rev Immunol 2014;14: 392-404
59. Naito M, Umeda S, Yamamoto T, et al. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J Leukoc Biol 1996;59: 133-138